5-methylcytosine hydroxylation-mediated LINE-1 hypomethylation: a novel mechanism of proto-oncogenes activation in colorectal cancer?

Por Belkhiri, Abbes, El-Rifai, Wael
Publicado em 2013

Advances in targeted therapies and new promising targets in esophageal cancer

Por Belkhiri, Abbes, El-Rifai, Wael
Publicado no Oncotarget (2015)

Therapeutic prospects for p73 and p63: Rising from the shadow of p53

Por Vilgelm, Anna, El-Rifai, Wael, Zaika, Alexander
Publicado em 2008

DARPP-32 Increases Interactions Between Epidermal Growth Factor Receptor and ERBB3 to Promote Tumor Resistance to Gefitinib

Por Zhu, Shoumin, Belkhiri, Abbes, El-Rifai, Wael
Publicado em 2011

DARPP-32: from neurotransmission to cancer

Por Belkhiri, Abbes, Zhu, Shoumin, El-Rifai, Wael
Publicado no Oncotarget (2016)

The Aurora kinase A Regulates GSK-3β in Gastric Cancer Cells

Por Dar, Altaf A, Belkhiri, Abbes, El-Rifai, Wael
Publicado em 2008

Aurora kinase A in gastrointestinal cancers: time to target

Por Katsha, Ahmed, Belkhiri, Abbes, Goff, Laura, El-Rifai, Wael
Publicado no Mol Cancer (2015)

The antioxidant response in Barrett's tumorigenesis: A double-edged sword

Por Peng, Dunfa, Zaika, Alexander, Que, Jianwen, El-Rifai, Wael
Publicado no Redox Biol (2021)

Targeted Molecular Therapies in the Treatment of Esophageal Adenocarcinoma, Are We There Yet?

Por Khalafi, Shayan, Lockhart, Albert Craig, Livingstone, Alan S., El-Rifai, Wael
Publicado no Cancers (Basel) (2020)

DNA Copy Number Changes in Development and Progression in Leiomyosarcomas of Soft Tissues

Por El-Rifai, Wa’el, Sarlomo-Rikala, Maarit, Knuutila, Sakari, Miettinen, Markku
Publicado em 1998

ESOPHAGEAL ADENOCARCINOMA: TREATMENT MODALITIES IN THE ERA OF TARGETED THERAPY

Por Mukherjee, Kaushik, Chakravarthy, A. Bapsi, Goff, Laura W., El-Rifai, Wael
Publicado em 2010

Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells

Por Vangamudi, Bhavatarini, Zhu, Shoumin, Soutto, Mohammed, Belkhiri, Abbes, El-Rifai, Wael
Publicado em 2011

Resistance to TRAIL is mediated by DARPP-32 in gastric cancer

Por Belkhiri, Abbes, Zhu, Shoumin, Chen, Zheng, Soutto, Mohammed, El-Rifai, Wael
Publicado em 2012

AURKA regulates JAK2–STAT3 activity in human gastric and esophageal cancers

Por Katsha, Ahmed, Arras, Janet, Soutto, Mohammed, Belkhiri, Abbes, El-Rifai, Wael
Publicado no Mol Oncol (2014)

Aurora Kinase A inhibition leads to p73-dependent apoptosis in p53-deficient cancer cells

Por Dar, Altaf A, Belkhiri, Abbes, Ecsedy, Jeffrey, Zaika, Alexander, El-Rifai, Wael
Publicado em 2008

Role of Bacterial and Viral Pathogens in Gastric Carcinogenesis

Por Palrasu, Manikandan, Zaika, Elena, El-Rifai, Wael, Que, Jianwen, Zaika, Alexander I.
Publicado no Cancers (Basel) (2021)

Aurora Kinases’ Inhibitors – Rising Stars in Cancer Therapeutics?

Por Dar, Altaf A, Goff, Laura W., Majid, Shahana, Berlin, Jordan, El-Rifai, Wael
Publicado em 2010

Regulation of ERBB2 Receptor by t-DARPP Mediates Trastuzumab Resistance in Human Esophageal Adenocarcinoma

Por Hong, Jun, Katsha, Ahmed, Lu, Pengcheng, Shyr, Yu, Belkhiri, Abbes, El-Rifai, Wael
Publicado em 2012

The Combination of Alisertib, an Investigational Aurora kinase A inhibitor, and Docetaxel Promotes Cell Death and Reduces Tumor Growth in Pre-Clinical Cell Models of Upper Gastroin...

Por Sehdev, Vikas, Katsha, Ahmed, Ecsedy, Jeffrey, Zaika, Alexander, Belkhiri, Abbes, El-Rifai, Wael
Publicado em 2012

Glutathione Peroxidase 7 Suppresses Bile Salt-Induced Expression of Pro-Inflammatory Cytokines in Barrett's Carcinogenesis

Por Peng, Dun-Fa, Hu, Tian-Ling, Soutto, Mohammed, Belkhiri, Abbes, El-Rifai, Wael
Publicado em 2014